Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiro Okami

Showing results (91-100 of 166) with videos related to

Pageof 17
Sort By:
Scientific Reports|August 19, 2018
Post-operative AICS status in completely resected lung cancer patients with pre-operative AICS abnormalities: predictive significance of disease recurrenceTakashi Anayama, Masahiko Higashiyama, Hiroshi Yamamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 26, 2016
[A Patient with Rectal Cancer and Multiple Lung Metastases Treated with XELOX plus Bevacizumab (Bev) Therapy]Shingo Noura, Masayuki Ohue, Norikatsu Miyoshi, et al.
International Journal of Clinical Oncology|April 10, 2024
Progressive changes in the protein expression profile of alveolar septa in early-stage lung adenocarcinomaToru Kimura, Takashi Akazawa, Yu Mizote, et al.
Hepato-Gastroenterology|May 17, 2003
The effect of beta-blocker on intractable ascites in cirrhotic patients undergoing hepatectomy for hepatocellular carcinomaMotoi Kondo, Hiroaki Nagano, Masato Sakon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 18, 2009
Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complicationsJiro Okami, Masahiko Higashiyama, Hisao Asamura, et al.
Lung Cancer (Amsterdam, Netherlands)|April 14, 2023
Clinical application of the AMOY 9-in-1 panel to lung cancer patientsKei Kunimasa, Shingo Matsumoto, Takahisa Kawamura, et al.
Surgery Today|March 13, 2009
Innate immune therapy with a Bacillus Calmette-Guérin cell wall skeleton after radical surgery for non-small cell lung cancer: a case-control studyKen Kodama, Masahiko Higashiyama, Koji Takami, et al.
Anticancer Research|August 19, 2007
Human equilibrative nucleoside transporter 1, as a predictor of 5-fluorouracil resistance in human pancreatic cancerMasanori Tsujie, Shoji Nakamori, Shin Nakahira, et al.
BMC Cancer|November 13, 2020
Preoperative AminoIndex Cancer Screening (AICS) abnormalities predict postoperative recurrence in patients undergoing curative resection for non-small cell lung cancerMasahiko Higashiyama, Ryohei Miyazaki, Hiroshi Yamamoto, et al.
International Journal of Molecular Medicine|November 21, 2008
Overexpression of MT1-MMP is insufficient to increase experimental liver metastasis of human colon cancer cellsHirofumi Yamamoto, Shingo Noura, Jiro Okami, et al.
Pageof 17

Showing results (91-100 of 166) with videos related to

Sort By:
Pageof 17
Scientific Reports|August 19, 2018
Post-operative AICS status in completely resected lung cancer patients with pre-operative AICS abnormalities: predictive significance of disease recurrenceTakashi Anayama, Masahiko Higashiyama, Hiroshi Yamamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 26, 2016
[A Patient with Rectal Cancer and Multiple Lung Metastases Treated with XELOX plus Bevacizumab (Bev) Therapy]Shingo Noura, Masayuki Ohue, Norikatsu Miyoshi, et al.
International Journal of Clinical Oncology|April 10, 2024
Progressive changes in the protein expression profile of alveolar septa in early-stage lung adenocarcinomaToru Kimura, Takashi Akazawa, Yu Mizote, et al.
Hepato-Gastroenterology|May 17, 2003
The effect of beta-blocker on intractable ascites in cirrhotic patients undergoing hepatectomy for hepatocellular carcinomaMotoi Kondo, Hiroaki Nagano, Masato Sakon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 18, 2009
Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complicationsJiro Okami, Masahiko Higashiyama, Hisao Asamura, et al.
Lung Cancer (Amsterdam, Netherlands)|April 14, 2023
Clinical application of the AMOY 9-in-1 panel to lung cancer patientsKei Kunimasa, Shingo Matsumoto, Takahisa Kawamura, et al.
Surgery Today|March 13, 2009
Innate immune therapy with a Bacillus Calmette-Guérin cell wall skeleton after radical surgery for non-small cell lung cancer: a case-control studyKen Kodama, Masahiko Higashiyama, Koji Takami, et al.
Anticancer Research|August 19, 2007
Human equilibrative nucleoside transporter 1, as a predictor of 5-fluorouracil resistance in human pancreatic cancerMasanori Tsujie, Shoji Nakamori, Shin Nakahira, et al.
BMC Cancer|November 13, 2020
Preoperative AminoIndex Cancer Screening (AICS) abnormalities predict postoperative recurrence in patients undergoing curative resection for non-small cell lung cancerMasahiko Higashiyama, Ryohei Miyazaki, Hiroshi Yamamoto, et al.
International Journal of Molecular Medicine|November 21, 2008
Overexpression of MT1-MMP is insufficient to increase experimental liver metastasis of human colon cancer cellsHirofumi Yamamoto, Shingo Noura, Jiro Okami, et al.
Pageof 17